I

Researcher Profile

Isabelle Genvresse

🏛 6Bayer Pharma AG, Berlin, Germany.

1

Publications

45

Citations

10

Co-Authors

1

Active Years

Publications

Journal Article Clinical Cancer Research Jan 18, 2022

First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy

Jennifer R. Diamond · Valentina Boni · Emerson Lim · Grzegorz Nowakowski +13 more

10.1158/1078-0432.ccr-21-3617 45 citations

Publication Timeline

2022

1

Frequent Co-Authors

Melanie M. Frigault

Grzegorz Nowakowski